Therapeutic Targeting of Autophagy

EBioMedicine

Volumn 14, Issue , 2016, Pages 15-23

  Towers, Christina G ^a   Thorburn, Andrew ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Autophagy; Cancer; Clinical trials; Neurodegenerative disease

Indexed keywords

ABIRATERONE; BERBERINE; BEVACIZUMAB; BORTEZOMIB; CALPASTATIN; CAPECITABINE PLUS OXALIPLATIN; CARBOPLATIN; CURCUMIN; CYCLOPHOSPHAMIDE; CYTOPROTECTIVE AGENT; DIMEBON; EVEROLIMUS; GEMCITABINE; LITHIUM; METFORMIN; NICOTINAMIDE; OXALIPLATIN; PACLITAXEL; RAPAMYCIN; RESVERATROL; RHEB PROTEIN; RILMENIDINE; SORAFENIB; SUNITINIB; TEMSIROLIMUS; TRAMETINIB; TREHALOSE; VORINOSTAT; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR;

ALZHEIMER DISEASE; AUTOPHAGY; CANCER THERAPY; CHAPERONE-MEDIATED AUTOPHAGY; DOWN REGULATION; DRUG MECHANISM; HUMAN; HUNTINGTON CHOREA; MACROAUTOPHAGY; MICROAUTOPHAGY; NEUROLOGIC DISEASE; NONHUMAN; PANCREAS CANCER; PARKINSON DISEASE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SMALL CELL LUNG CANCER; UPREGULATION; ANIMAL; CLINICAL TRIAL (TOPIC); DRUG EFFECTS; METABOLISM; NEOPLASMS; NEURODEGENERATIVE DISEASES;

ANIMALS; ANTINEOPLASTIC AGENTS; AUTOPHAGY; CLINICAL TRIALS AS TOPIC; ENZYME INHIBITORS; HUMANS; NEOPLASMS; NEURODEGENERATIVE DISEASES;

EID: 85003956475     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.10.034     Document Type: Review

References (124)

1. Akin, D., Wang, S.K., Habibzadegah-Tari, P., Law, B., Ostrov, D., Li, M., Yin, X.-M., Kim, J.-S., Horenstein, N., Dunn, W.A., A novel ATG4B antagonist inhibits autophagy and has a negative impact on osteosarcoma tumors. Autophagy 10 (2014), 2021–2035.
2. Amaravadi, R.K., Transcriptional regulation of autophagy in RAS-driven cancers. J. Clin. Invest. 125 (2015), 1393–1395.
3. Arias, E., Koga, H., Diaz, A., Mocholi, E., Patel, B., Cuervo, A.M., Lysosomal mTORC2/PHLPP1/Akt regulate chaperone-mediated autophagy. Mol. Cell 59 (2015), 270–284.
4. Baginska, J., Viry, E., Berchem, G., Poli, A., Noman, M.Z., Van Moer, K., Medves, S., Zimmer, J., Oudin, A., Niclou, S.P., Bleackley, R.C., Goping, I.S., Chouaib, S., Janji, B., Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 17450–17455.
5. Bago, R., Malik, N., Munson, M.J., Prescott, A.R., Davies, P., Sommer, E., Shpiro, N., Ward, R., Cross, D., Ganley, I.G., Alessi, D.R., Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase. Biochem. J. 463 (2014), 413–427.
6. Barnard, R.A., Wittenburg, L.A., Amaravadi, R.K., Gustafson, D.L., Thorburn, A., Thamm, D.H., Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma. Autophagy 10 (2014), 1415–1425.
7. Billes, V., Kovacs, T., Hotzi, B., Manzeger, A., Tagscherer, K., Komlos, M., Tarnoci, A., Padar, Z., Erdos, A., Bjelik, A., Legradi, A., Gulya, K., Gulyas, B., Vellai, T., AUTEN-67 (autophagy enhancer-67) hampers the progression of neurodegenerative symptoms in a Drosophila model of Huntington's disease. J. Huntingtons Dis., 2016.
8. Caccamo, A., Majumder, S., Richardson, A., Strong, R., Oddo, S., Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J. Biol. Chem. 285 (2010), 13107–13120.
9. Chen, S., Wang, C., Yeo, S., Liang, C.-C., Okamoto, T., Sun, S., Wen, J., Guan, J.-L., Distinct roles of autophagy-dependent and -independent functions of FIP200 revealed by generation and analysis of a mutant knock-in mouse model. Genes Dev. 30 (2016), 856–869.
10. Cianfanelli, V., Fuoco, C., Lorente, M., Salazar, M., Quondamatteo, F., Gherardini, P.F., de Zio, D., Nazio, F., Antonioli, M., D'orazio, M., Skobo, T., Bordi, M., Rohde, M., Dalla Valle, L., Helmer-Citterich, M., Gretzmeier, C., Dengjel, J., Fimia, G.M., Piacentini, M., Di Bartolomeo, S., Velasco, G., Cecconi, F., AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation. Nat. Cell Biol., 17, 2015, 706.
11. Cicchini, M., Chakrabarti, R., Kongara, S., Price, S., Nahar, R., Lozy, F., Zhong, H., Vazquez, A., Kang, Y., Karantza, V., Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. Autophagy 10 (2014), 2036–2052.
12. Coppola, D., Khalil, F., Eschrich, S.A., Boulware, D., Yeatman, T., Wang, H.G., Down-regulation of Bax-interacting factor-1 in colorectal adenocarcinoma. Cancer 113 (2008), 2665–2670.
13. Cuervo, A.M., Wong, E., Chaperone-mediated autophagy: roles in disease and aging. Cell Res. 24 (2014), 92–104.
14. Debosch, B.J., Heitmeier, M.R., Mayer, A.L., Higgins, C.B., Crowley, J.R., Kraft, T.E., Chi, M., Newberry, E.P., Chen, Z., Finck, B.N., Davidson, N.O., Yarasheski, K.E., Hruz, P.W., Moley, K.H., Trehalose inhibits solute carrier 2A (SLC2A) proteins to induce autophagy and prevent hepatic steatosis. Sci. Signal., 9, 2016, ra21.
15. Decressac, M., Mattsson, B., Weikop, P., Lundblad, M., Jakobsson, J., Bjorklund, A., TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-ynuclein toxicity. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), E1817–E1826.
16. Dowdle, W.E., Nyfeler, B., Nagel, J., Elling, R.A., Liu, S., Triantafellow, E., Menon, S., Wang, Z., Honda, A., Pardee, G., Cantwell, J., Luu, C., Cornella-Taracido, I., Harrington, E., Fekkes, P., Lei, H., Fang, Q., Digan, M.E., Burdick, D., Powers, A.F., Helliwell, S.B., D'aquin, S., Bastien, J., Wang, H., Wiederschain, D., Kuerth, J., Bergman, P., Schwalb, D., Thomas, J., Ugwonali, S., Harbinski, F., Tallarico, J., Wilson, C.J., Myer, V.E., Porter, J.A., Bussiere, D.E., Finan, P.M., Labow, M.A., Mao, X., Hamann, L.G., Manning, B.D., Valdez, R.A., Nicholson, T., Schirle, M., Knapp, M.S., Keaney, E.P., Murphy, L.O., Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo. Nat. Cell Biol., 2014.
17. Egan, D.F., Chun, M.G.H., Vamos, M., Zou, H., Rong, J., Miller, C.J., Lou, H.J., Raveendra-Panickar, D., Yang, C.-C., Sheffler, D.J., Teriete, P., Asara, J.M., Turk, B.E., Cosford, N.D.P., Shaw, R.J., Small molecule inhibition of the autophagy kinase ULK1 and identification of ULK1 substrates. Mol. Cell 59 (2015), 285–297.
18. Eng, C.H., Wang, Z., Tkach, D., Toral-Barza, L., Ugwonali, S., Liu, S., Fitzgerald, S.L., George, E., Frias, E., Cochran, N., de Jesus, R., Mcallister, G., Hoffman, G.R., Bray, K., Lemon, L., Lucas, J., Fantin, V.R., Abraham, R.T., Murphy, L.O., Nyfeler, B., Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 182–187.
19. Forlenza, O.V., de Paula, V.J., Machado-Vieira, R., Diniz, B.S., Gattaz, W.F., Does lithium prevent Alzheimer's disease?. Drugs Aging 29 (2012), 335–342.
20. Füllgrabe, J., Klionsky, D.J., Joseph, B., The return of the nucleus: transcriptional and epigenetic control of autophagy. Nat. Rev. Mol. Cell Biol. 15 (2014), 65–74.
21. Guo, J.Y., Chen, H.Y., mathew, r., Fan, J., Strohecker, A.M., Karsli-Uzunbas, G., Kamphorst, J.J., Chen, G., Lemons, J.M., Karantza, V., Coller, H.A., Dipaola, R.S., Gelinas, C., Rabinowitz, J.D., White, E., Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 25 (2011), 460–470.
22. Guo, J.Y., Karsli-Uzunbas, G., Mathew, R., Aisner, S.C., Kamphorst, J.J., Strohecker, A.M., Chen, G., Price, S., Lu, W., Teng, X., Snyder, E., Santanam, U., Dipaola, R.S., Jacks, T., Rabinowitz, J.D., White, E., Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev. 27 (2013), 1447–1461.
23. Guo, J.Y., Teng, X., Laddha, S.V., Ma, S., Van Nostrand, S.C., Yang, Y., Khor, S., Chan, C.S., Rabinowitz, J.D., White, E., Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells. Genes Dev. 30 (2016), 1704–1717.
24. He, C., Bassik, M.C., Moresi, V., Sun, K., Wei, Y., Zou, Z., An, Z., Loh, J., Fisher, J., Sun, Q., Korsmeyer, S., Packer, M., May, H.I., Hill, J.A., Virgin, H.W., Gilpin, C., Xiao, G., Bassel-Duby, R., Scherer, P.E., Levine, B., Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 481 (2012), 511–515.
25. Itakura, E., Kishi-Itakura, C., Mizushima, N., The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell 151 (2012), 1256–1269.
26. Ivachtchenko, A.V., Lavrovsky, Y., Ivanenkov, Y.A., AVN-211, novel and highly selective 5-HT6 receptor small molecule antagonist, for the treatment of Alzheimer's disease. Mol. Pharm. 13 (2016), 945–963.
27. Ji, H.F., Shen, L., The multiple pharmaceutical potential of curcumin in Parkinson's disease. CNS Neurol. Disord. Drug Targets 13 (2014), 369–373.
28. Jiang, W., Wei, W., Gaertig, M.A., Li, S., Li, X.J., Therapeutic effect of berberine on Huntington's disease transgenic mouse model. PLoS One, 10, 2015, e0134142.
29. Karsli-Uzunbas, G., Guo, J.Y., Price, S., Teng, X., Laddha, S.V., Khor, S., Kalaany, N.Y., Jacks, T., Chan, C.S., Rabinowitz, J.D., White, E., Autophagy is required for glucose homeostasis and lung tumor maintenance. Cancer Discov. 4 (2014), 914–927.
30. Kenific, C.M., Thorburn, A., Debnath, J., Autophagy and metastasis: another double-edged sword. Curr. Opin. Cell Biol. 22 (2010), 241–245.
31. Kenific, C.M., Stehbens, S.J., Goldsmith, J., Leidal, A.M., Faure, N., Ye, J., Wittmann, T., Debnath, J., NBR1 enables autophagy-dependent focal adhesion turnover. J. Cell Biol. 212 (2016), 577–590.
32. Kickstein, E., Krauss, S., Thornhill, P., Rutschow, D., Zeller, R., Sharkey, J., Williamson, R., Fuchs, M., Kohler, A., Glossmann, H., Schneider, R., Sutherland, C., Schweiger, S., Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 21830–21835.
33. Kim, M., Sandford, E., Gatica, D., Qiu, Y., Liu, X., Zheng, Y., Schulman, B.A., Xu, J., Semple, I., Ro, S.-H., Kim, B., Mavioglu, R.N., Tolun, A., Jipa, A., Takats, S., Karpati, M., Li, J.Z., Yapici, Z., Juhasz, G., Lee, J.H., Klionsky, D.J., Burmeister, M., Mutation in ATG5 reduces autophagy and leads to ataxia with developmental delay. eLife, 5, 2016.
34. Klionsky, D.J., Abdelmohsen, K., Abe, A., Abedin, M.J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C.M., Adams, P.D., Adeli, K., Adhihetty, P.J., Adler, S.G., Agam, G., Agarwal, R., Aghi, M.K., Agnello, M., Agostinis, P., Aguilar, P.V., Aguirre-Ghiso, J., Airoldi, E.M., Ait-Si-Ali, S., Akematsu, T., Akporiaye, E.T., AL-Rubeai, M., Albaiceta, G.M., Albanese, C., Albani, D., Albert, M.L., Aldudo, J., Algül, H., Alirezaei, M., Alloza, I., Almasan, A., Almonte-Beceril, M., Alnemri, E.S., Alonso, C., Altan-Bonnet, N., Altieri, D.C., Alvarez, S., Alvarez-Erviti, L., Alves, S., Amadoro, G., Amano, A., Amantini, C., Ambrosio, S., Amelio, I., Amer, A.O., Amessou, M., Amon, A., An, Z., Anania, F.A., Andersen, S.U., Andley, U.P., Andreadi, C.K., Andrieu-Abadie, N., Anel, A., Ann, D.K., Anoopkumar-Dukie, S., Antonioli, M., Aoki, H., Apostolova, N., Aquila, S., Aquilano, K., Araki, K., Arama, E., Aranda, A., Araya, J., Arcaro, A., Arias, E., Arimoto, H., Ariosa, A.R., Armstrong, J.L., Arnould, T., Arsov, I., Asanuma, K., Askanas, V., Asselin, E., Atarashi, R., Atherton, S.S., Atkin, J.D., Attardi, L.D., Auberger, P., Auburger, G., Aurelian, L., Autelli, R., Avagliano, L., Avantaggiati, M.L., Avrahami, L., Awale, S., Azad, N., Bachetti, T., Backer, J.M., Bae, D.-H., Bae, J.-S., Bae, O.-N., Bae, S.H., Baehrecke, E.H., Baek, S.-H., Baghdiguian, S., Bagniewska-Zadworna, A., et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12 (2016), 1–222.
35. Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., Ohsumi, Y., Uchiyama, Y., Kominami, E., Tanaka, K., Chiba, T., Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J. Cell Biol. 169 (2005), 425–434.
36. Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., Tanaka, K., Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441 (2006), 880–884.
37. Laddha, S.V., Ganesan, S., Chan, C.S., White, E., Mutational landscape of the essential autophagy Gene BECN1 in human cancers. Mol. Cancer Res. 12 (2014), 485–490.
38. Lastres-Becker, I., Garcia-Yague, A.J., Scannevin, R.H., Casarejos, M.J., Kugler, S., Rabano, A., Cuadrado, A., Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson's disease. Antioxid. Redox Signal., 2016.
39. Lee, J.H., Tecedor, L., Chen, Y.H., Monteys, A.M., Sowada, M.J., Thompson, L.M., Davidson, B.L., Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes. Neuron 85 (2015), 303–315.
40. levine, B., Packer, M., Codogno, P., Development of autophagy inducers in clinical medicine. J. Clin. Invest. 125 (2015), 14–24.
41. Levy, J.M.M., Thompson, J.C., Griesinger, A.M., Amani, V., Donson, A.M., Birks, D.K., Morgan, M.J., Mirsky, D.M., Handler, M.H., Foreman, N.K., Thorburn, A., Autophagy inhibition improves chemosensitivity in BRAFV600E brain tumors. Cancer Discov 4 (2014), 773–780.
42. Li, W.W., Li, J., Bao, J.K., Microautophagy: lesser-known self-eating. Cell. Mol. Life Sci. 69 (2012), 1125–1136.
43. Li, J., Kim, S.G., Blenis, J., Rapamycin: one drug, many effects. Cell Metab. 19 (2014), 373–379.
44. Liang, X.H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., Levine, B., Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402 (1999), 672–676.
45. Liang, C., Feng, P., Ku, B., Dotan, I., Canaani, D., Oh, B.H., Jung, J.U., Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat. Cell Biol. 8 (2006), 688–699.
46. Liang, X., de Vera, M.E., Buchser, W.J., Romo de Vivar Chavez, A., Loughran, P., Beer Stolz, D., Basse, P., Wang, T., van Houten, B., Zeh, H.J., Lotze, M.T., Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression. Cancer Res. 72 (2012), 2791–2801.
47. Lin, T.K., Chen, S.D., Chuang, Y.C., Lin, H.Y., Huang, C.R., Chuang, J.H., Wang, P.W., Huang, S.T., Tiao, M.M., Chen, J.B., Liou, C.W., Resveratrol partially prevents rotenone-induced neurotoxicity in dopaminergic SH-SY5Y cells through induction of heme oxygenase-1 dependent autophagy. Int. J. Mol. Sci. 15 (2014), 1625–1646.
48. Liu, D., Pitta, M., Jiang, H., Lee, J.H., Zhang, G., Chen, X., Kawamoto, E.M., Mattson, M.P., Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession. Neurobiol. Aging 34 (2013), 1564–1580.
49. Lock, R., Roy, S., Kenific, C.M., Su, J.S., Salas, E., Ronen, S.M., Debnath, J., Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol. Biol. Cell 22 (2011), 165–178.
50. Lock, R., Kenific, C.M., Leidal, A.M., Salas, E., Debnath, J., Autophagy-dependent production of secreted factors facilitates oncogenic RAS-driven invasion. Cancer Discov. 4 (2014), 466–479.
51. Ma, X.-H., Piao, S.-F., Dey, S., Mcafee, Q., Karakousis, G., Villanueva, J., Hart, L.S., Levi, S., Hu, J., Zhang, G., Lazova, R., Klump, V., Pawelek, J.M., Xu, X., Xu, W., Schuchter, L.M., Davies, M.A., Herlyn, M., Winkler, J., Koumenis, C., Amaravadi, R.K., Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma. J. Clin. Invest. 124 (2014), 1406–1417.
52. Madrigal-Matute, J., Cuervo, A.M., Regulation of liver metabolism by autophagy. Gastroenterology 150 (2016), 328–339.
53. Mahalingam, D., Mita, M., Sarantopoulos, J., Wood, L., Amaravadi, R.K., Davis, L.E., Mita, A.C., Curiel, T.J., Espitia, C.M., Nawrocki, S.T., Giles, F.J., Carew, J.S., Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors. Autophagy 10 (2014), 1403–1414.
54. Maher-Edwards, G., Zvartau-Hind, M., Hunter, A.J., Gold, M., Hopton, G., Jacobs, G., Davy, M., Williams, P., Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457, in Alzheimer's disease. Curr. Alzheimer Res. 7 (2010), 374–385.
55. Maiuri, M.C., Le Toumelin, G., Criollo, A., Rain, J.C., Gautier, F., Juin, P., Tasdemir, E., Pierron, G., Troulinaki, K., Tavernarakis, N., Hickman, J.A., Geneste, O., Kroemer, G., Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J. 26 (2007), 2527–2539.
56. Martinez-Vicente, M., Talloczy, Z., Wong, E., Tang, G., Koga, H., Kaushik, S., de Vries, R., Arias, E., Harris, S., Sulzer, D., Cuervo, A.M., Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease. Nat. Neurosci. 13 (2010), 567–576.
57. Maycotte, P., Aryal, S., Cummings, C.T., Thorburn, J., Morgan, M.J., Thorburn, A., Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy 8 (2012), 200–212.
58. Maycotte, P., Gearheart, C.M., Barnard, R., Aryal, S., Mulcahy Levy, J.M., Fosmire, S.P., Hansen, R.J., Morgan, M.J., Porter, C.C., Gustafson, D.L., Thorburn, A., STAT3-mediated autophagy dependence identifies subtypes of breast cancer where autophagy inhibition can be efficacious. Cancer Res. 74 (2014), 2579–2590.
59. Meffre, J., Chaumont-Dubel, S., Mannoury La Cour, C., Loiseau, F., Watson, D.J., Dekeyne, A., Seveno, M., Rivet, J.M., Gaven, F., Deleris, P., Herve, D., Fone, K.C., Bockaert, J., Millan, M.J., Marin, P., 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. EMBO Mol. Med. 4 (2012), 1043–1056.
60. Menzies, F.M., Garcia-Arencibia, M., Imarisio, S., O'sullivan, N.C., Ricketts, T., Kent, B.A., Rao, M.V., Lam, W., Green-Thompson, Z.W., Nixon, R.A., Saksida, L.M., Bussey, T.J., O'kane, C.J., Rubinsztein, D.C., Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity. Cell Death Differ. 22 (2015), 433–444.
61. Michaud, M., Martins, I., Sukkurwala, A.Q., Adjemian, S., Ma, Y., Pellegatti, P., Shen, S., Kepp, O., Scoazec, M., Mignot, G., Rello-Varona, S., Tailler, M., Menger, L., Vacchelli, E., Galluzzi, L., Ghiringhelli, F., Di Virgilio, F., Zitvogel, L., Kroemer, G., Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 334 (2011), 1573–1577.
62. Mizushima, N., Yoshimori, T., Ohsumi, Y., The role of Atg proteins in autophagosome formation. Annu. Rev. Cell Dev. Biol. 27 (2011), 107–132.
63. Morgan, M.J., Gamez, G., Menke, C., Hernandez, A., Thorburn, J., Gidan, F., Staskiewicz, L., Morgan, S., Cummings, C., Maycotte, P., Thorburn, A., Regulation of autophagy and chloroquine sensitivity by oncogenic RAS in vitro is context-dependent. Autophagy 10 (2014), 1814–1826.
64. Morozova, M.A., Lepilkina, T.A., Rupchev, G.E., Beniashvily, A.G., Burminskiy, D.S., Potanin, S.S., Bondarenko, E.V., Kazey, V.I., Lavrovsky, Y., Ivachtchenko, A.V., Add-on clinical effects of selective antagonist of 5HT6 receptors AVN-211 (CD-008-0173) in patients with schizophrenia stabilized on antipsychotic treatment: pilot study. CNS Spectr. 19 (2014), 316–323.
65. Nah, J., Yuan, J., Jung, Y.K., Autophagy in neurodegenerative diseases: from mechanism to therapeutic approach. Mol. Cell 38 (2015), 381–389.
66. Narendra, D., Tanaka, A., Suen, D.F., Youle, R.J., Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 183 (2008), 795–803.
67. Novak, M.J., Tabrizi, S.J., Huntington's disease. BMJ, 340, 2010, c3109.
68. Papp, D., Kovacs, T., Billes, V., Varga, M., Tarnoci, A., Hackler, L. Jr., Puskas, L.G., Liliom, H., Tarnok, K., Schlett, K., Borsy, A., Padar, Z., Kovacs, A.L., Hegedus, K., Juhasz, G., Komlos, M., Erdos, A., Gulyas, B., Vellai, T., AUTEN-67, an autophagy-enhancing drug candidate with potent antiaging and neuroprotective effects. Autophagy 12 (2016), 273–286.
69. Park, S.M., Ou, J., Chamberlain, L., Simone, T.M., Yang, H., Virbasius, C.M., Ali, A.M., Zhu, L.J., Mukherjee, S., Raza, A., Green, M.R., U2AF35(S34F) promotes transformation by directing aberrant ATG7 pre-mRNA 3′ end formation. Mol. Cell 62 (2016), 479–490.
70. Patel, S., Hurez, V., Nawrocki, S.T., Goros, M., Michalek, J., Sarantopoulos, J., Curiel, T., Mahalingam, D., Vorinostat and hydroxychloroquine improve immunity and inhibit autophagy in metastatic colorectal cancer. Oncotarget, 2016.
71. Pellegrini, P., Strambi, A., Zipoli, C., Hägg-Olofsson, M., Buoncervello, M., Linder, S., de Milito, A., Acidic extracellular pH neutralizes the autophagy-inhibiting activity of chloroquine: implications for cancer therapies. Autophagy 10 (2014), 562–571.
72. Perera, R.M., Stoykova, S., Nicolay, B.N., Ross, K.N., Fitamant, J., Boukhali, M., Lengrand, J., Deshpande, V., Selig, M.K., Ferrone, C.R., Settleman, J., Stephanopoulos, G., Dyson, N.J., Zoncu, R., Ramaswamy, S., Haas, W., Bardeesy, N., Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism. Nature 524 (2015), 361–365.
73. Petherick, K.J., Conway, O.J.L., Mpamhanga, C., Osborne, S.A., Kamal, A., Saxty, B., Ganley, I.G., Pharmacological inhibition of ULK1 kinase blocks mammalian target of rapamycin (mTOR)-dependent autophagy. J. Biol. Chem. 290 (2015), 11376–11383.
74. Pietrocola, F., Pol, J., Vacchelli, E., Rao, S., Enot, D.P., Baracco, E.E., Levesque, S., Castoldi, F., Jacquelot, N., Yamazaki, T., Senovilla, L., Marino, G., Aranda, F., Durand, S., Sica, V., Chery, A., Lachkar, S., Sigl, V., Bloy, N., Buque, A., Falzoni, S., Ryffel, B., Apetoh, L., Di Virgilio, F., Madeo, F., Maiuri, M.C., Zitvogel, L., Levine, B., Penninger, J.M., Kroemer, G., Caloric restriction mimetics enhance anticancer immunosurveillance. Cancer Cell 30 (2016), 147–160.
75. Qu, X., Zou, Z., Sun, Q., Luby-Phelps, K., Cheng, P., Hogan, R.N., Gilpin, C., Levine, B., Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 128 (2007), 931–946.
76. Querfurth, H.W., Laferla, F.M., Alzheimer's disease. N. Engl. J. Med. 362 (2010), 329–344.
77. Rangwala, R., Chang, Y.C., Hu, J., Algazy, K.M., Evans, T.L., Fecher, L.A., Schuchter, L.M., Torigian, D.A., Panosian, J.T., Troxel, A.B., Tan, K.S., Heitjan, D.F., Demichele, A.M., Vaughn, D.J., Redlinger, M., Alavi, A., Kaiser, J., Pontiggia, L., Davis, L.E., O'Dwyer, P.J., Amaravadi, R.K., Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma. Autophagy 10 (2014), 1391–1402.
78. Rangwala, R., Leone, R., Chang, Y.C., Fecher, L.A., Schuchter, L.M., Kramer, A., Tan, K.S., Heitjan, D.F., Rodgers, G., Gallagher, M., Piao, S., Troxel, A.B., Evans, T.L., Demichele, A.M., Nathanson, K.L., O'Dwyer, P.J., Kaiser, J., Pontiggia, L., Davis, L.E., Amaravadi, R.K., Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. Autophagy 10 (2014), 1369–1379.
79. Rao, S., Tortola, L., Perlot, T., Wirnsberger, G., Novatchkova, M., Nitsch, R., Sykacek, P., Frank, L., Schramek, D., Komnenovic, V., Sigl, V., Aumayr, K., Schmauss, G., Fellner, N., Handschuh, S., Glosmann, M., Pasierbek, P., Schlederer, M., Resch, G.P., Ma, Y., Yang, H., Popper, H., Kenner, L., Kroemer, G., Penninger, J.M., A dual role for autophagy in a murine model of lung cancer. Nat. Commun., 5, 2014, 3056.
80. Ravikumar, B., Vacher, C., Berger, Z., Davies, J.E., Luo, S., Oroz, L.G., Scaravilli, F., Easton, D.F., Duden, R., O'kane, C.J., Rubinsztein, D.C., Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36 (2004), 585–595.
81. Rebecca, V.W., Amaravadi, R.K., Emerging strategies to effectively target autophagy in cancer. Oncogene, 2015.
82. Reljic, B., Conos, S., Lee, E.F., Garnier, J.-M., Dong, L., Lessene, G., Fairlie, W.D., Vaux, D.L., Lindqvist, L.M., BAX-BAK1-independent LC3B lipidation by BH3 mimetics is unrelated to BH3 mimetic activity and has only minimal effects on autophagic flux. Autophagy 12 (2016), 1083–1093.
83. Rojas-Puentes, L.L., Gonzalez-Pinedo, M., Crismatt, A., Ortega-Gomez, A., Gamboa-Vignolle, C., Nunez-Gomez, R., Dorantes-Gallareta, Y., Arce-Salinas, C., Arrieta, O., Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases. Radiat. Oncol., 8, 2013, 209.
84. Ronan, B., Flamand, O., Vescovi, L., Dureuil, C., Durand, L., Fassy, F., Bachelot, M.-F., Lamberton, A., Mathieu, M., Bertrand, T., marquette, J.-P., El-ahmad, Y., Filoche-Romme, B., Schio, L., Garcia-Echeverria, C., Goulaouic, H., Pasquier, B., A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy. Nat. Chem. Biol. 10 (2014), 1013–1019.
85. Rose, C., Menzies, F.M., Renna, M., Acevedo-Arozena, A., Corrochano, S., Sadiq, O., Brown, S.D., Rubinsztein, D.C., Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease. Hum. Mol. Genet. 19 (2010), 2144–2153.
86. Rosenfeld, M.R., Ye, X., Supko, J.G., Desideri, S., Grossman, S.A., Brem, S., Mikkelson, T., Wang, D., Chang, Y.C., Hu, J., Mcafee, Q., Fisher, J., Troxel, A.B., Piao, S., Heitjan, D.F., Tan, K.S., Pontiggia, L., O'Dwyer, P.J., Davis, L.E., Amaravadi, R.K., A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme. Autophagy 10 (2014), 1359–1368.
87. Rosenfeldt, M.T., O'Prey, J., Morton, J.P., Nixon, C., Mackay, G., Mrowinska, A., Au, A., Rai, T.S., Zheng, L., Ridgway, R., Adams, P.D., Anderson, K.I., Gottlieb, E., Sansom, O.J., Ryan, K.M., p53 status determines the role of autophagy in pancreatic tumour development. Nature 504 (2013), 296–300.
88. Rub, C., Wilkening, A., Voos, W., Mitochondrial quality control by the Pink1/Parkin system. Cell Tissue Res., 2016.
89. Rubinsztein, D.C., Codogno, P., Levine, B., Autophagy modulation as a potential therapeutic target for diverse diseases. Nat. Rev. Drug Discov. 11 (2012), 709–730.
90. Rubinsztein, D.C., Bento, C.F., Deretic, V., Therapeutic targeting of autophagy in neurodegenerative and infectious diseases. J. Exp. Med. 212 (2015), 979–990.
91. Santanam, U., Banach-Petrosky, W., Abate-Shen, C., Shen, M.M., White, E., Dipaola, R.S., Atg7 cooperates with Pten loss to drive prostate cancer tumor growth. Genes Dev. 30 (2016), 399–407.
92. Sarkar, S., Rubinsztein, D.C., Huntington's disease: degradation of mutant huntingtin by autophagy. FEBS J. 275 (2008), 4263–4270.
93. Sarkar, S., Davies, J.E., Huang, Z., Tunnacliffe, A., Rubinsztein, D.C., Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J. Biol. Chem. 282 (2007), 5641–5652.
94. Sarkar, S., Perlstein, E.O., Imarisio, S., Pineau, S., Cordenier, A., Maglathlin, R.L., Webster, J.A., Lewis, T.A., O'Kane, C.J., Schreiber, S.L., Rubinsztein, D.C., Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat. Chem. Biol. 3 (2007), 331–338.
95. Sharifi, M.N., Mowers, E.E., Drake, L.E., Collier, C., Chen, H., Zamora, M., Mui, S., Macleod, K.F., Autophagy promotes focal adhesion disassembly and cell motility of metastatic tumor cells through the direct interaction of paxillin with LC3. Cell Rep. 15 (2016), 1660–1672.
96. Shibuya, Y., Niu, Z., Bryleva, E.Y., Harris, B.T., Murphy, S.R., Kheirollah, A., Bowen, Z.D., Chang, C.C., Chang, T.Y., Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage. Neurobiol. Aging 36 (2015), 2248–2259.
97. Shoji-Kawata, S., Sumpter, R., Leveno, M., Campbell, G.R., Zou, Z., Kinch, L., Wilkins, A.D., Sun, Q., Pallauf, K., Macduff, D., Huerta, C., Virgin, H.W., Helms, J.B., Eerland, R., Tooze, S.A., Xavier, R., Lenschow, D.J., Yamamoto, A., King, D., Lichtarge, O., Grishin, N.V., Spector, S.A., Kaloyanova, D.V., Levine, B., Identification of a candidate therapeutic autophagy-inducing peptide. Nature 494 (2013), 201–206.
98. Siman, R., Cocca, R., Dong, Y., The mTOR inhibitor rapamycin mitigates perforant pathway neurodegeneration and synapse loss in a mouse model of early-stage Alzheimer-type tauopathy. PLoS One, 10, 2015, e0142340.
99. Sinha, S., Levine, B., The autophagy effector Beclin 1: a novel BH3-only protein. Oncogene 27:Suppl 1 (2008), S137–S148.
100. Song, J.X., Sun, Y.R., Peluso, I., Zeng, Y., Yu, X., Lu, J.H., Xu, Z., Wang, M.Z., Liu, L.F., Huang, Y.Y., Chen, L.L., Durairajan, S.S., Zhang, H.J., Zhou, B., Zhang, H.Q., Lu, A., Ballabio, A., Medina, D.L., Guo, Z., Li, M., A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition. Autophagy, 2016, 1–18.
101. Sousa, C.M., Biancur, D.E., Wang, X., Halbrook, C.J., Sherman, M.H., Zhang, L., Kremer, D., Hwang, R.F., Witkiewicz, A.K., Ying, H., Asara, J.M., Evans, R.M., Cantley, L.C., Lyssiotis, C.A., Kimmelman, A.C., Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature 536 (2016), 479–483.
102. Spencer, B., Potkar, R., Trejo, M., Rockenstein, E., Patrick, C., Gindi, R., Adame, A., Wyss-Coray, T., Masliah, E., Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases. J. Neurosci. 29 (2009), 13578–13588.
103. Steele, J.W., Gandy, S., Latrepirdine (Dimebon(R)), a potential Alzheimer therapeutic, regulates autophagy and neuropathology in an Alzheimer mouse model. Autophagy 9 (2013), 617–618.
104. Strohecker, A.M., Guo, J.Y., Karsli-Uzunbas, G., Price, S.M., Chen, G.J., Mathew, R., Mcmahon, M., White, E., Autophagy sustains mitochondrial glutamine metabolism and growth of BRAFV600E-driven lung tumors. Cancer Discov. 3 (2013), 1272–1285.
105. Surendran, S., Rajasankar, S., Parkinson's disease: oxidative stress and therapeutic approaches. Neurol. Sci. 31 (2010), 531–540.
106. Tang, H., Sebti, S., Titone, R., Zhou, Y., Isidoro, C., Ross, T.S., Hibshoosh, H., Xiao, G., Packer, M., Xie, Y., Levine, B., Decreased BECN1 mRNA expression in human breast cancer is associated with estrogen receptor-negative subtypes and poor prognosis. EBioMedicine 2 (2015), 255–263.
107. Thorburn, A., Thamm, D.H., Gustafson, D.L., Autophagy and cancer therapy. Mol. Pharmacol. 85 (2014), 830–838.
108. Vander Heiden, M.G., Cantley, L.C., Thompson, C.B., Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324 (2009), 1029–1033.
109. Vingtdeux, V., Giliberto, L., Zhao, H., Chandakkar, P., Wu, Q., Simon, J.E., Janle, E.M., Lobo, J., Ferruzzi, M.G., Davies, P., Marambaud, P., AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J. Biol. Chem. 285 (2010), 9100–9113.
110. Vogl, D.T., Stadtmauer, E.A., Tan, K.S., Heitjan, D.F., Davis, L.E., Pontiggia, L., Rangwala, R., Piao, S., Chang, Y.C., Scott, E.C., Paul, T.M., Nichols, C.W., Porter, D.L., Kaplan, J., Mallon, G., Bradner, J.E., Amaravadi, R.K., Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma. Autophagy 10 (2014), 1380–1390.
111. Wang, J.Z., Xia, Y.Y., Grundke-Iqbal, I., Iqbal, K., Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. J. Alzheimers Dis. 33:Suppl 1 (2013), S123–S139.
112. Wang, H.C., Zhang, T., Kuerban, B., Jin, Y.L., Le, W., Hara, H., Fan, D.S., Wang, Y.J., Tabira, T., Chui, D.H., Autophagy is involved in oral rAAV/Abeta vaccine-induced Abeta clearance in APP/PS1 transgenic mice. Neurosci. Bull. 31 (2015), 491–504.
113. Wei, H., Wang, C., Croce, C.M., Guan, J.-L., p62/SQSTM1 synergizes with autophagy for tumor growth in vivo. Genes Dev. 28 (2014), 1204–1216.
114. White, E., The role for autophagy in cancer. J. Clin. Invest. 125 (2015), 42–46.
115. Wilkinson, D., Windfeld, K., Colding-Jorgensen, E., Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol. 13 (2014), 1092–1099.
116. Wolpin, B.M., Rubinson, D.A., Wang, X., Chan, J.A., Cleary, J.M., Enzinger, P.C., Fuchs, C.S., Mccleary, N.J., Meyerhardt, J.A., Ng, K., Schrag, D., Sikora, A.L., Spicer, B.A., Killion, L., Mamon, H., Kimmelman, A.C., Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma. Oncologist 19 (2014), 637–638.
117. Wong, Y.C., Holzbaur, E.L., The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation. J. Neurosci. 34 (2014), 1293–1305.
118. Xie, X., Koh, J.Y., Price, S., White, E., Mehnert, J.M., Atg7 overcomes senescence and promotes growth of BrafV600E-driven melanoma. Cancer Discov. 5 (2015), 410–423.
119. Yang, S., Wang, X., Contino, G., liesa, M., Sahin, E., Ying, H., Bause, A., Li, Y., Stommel, J.M., Dell'Antonio, G., Mautner, J., Tonon, G., Haigis, M., Shirihai, O.S., Doglioni, C., Bardeesy, N., Kimmelman, A.C., Pancreatic cancers require autophagy for tumor growth. Genes Dev. 25 (2011), 717–729.
120. Yang, A., Rajeshkumar, N.V., wang, X., Yabuuchi, S., Alexander, B.M., Chu, G.C., von Hoff, D.D., MAITRA, A., Kimmelman, A.C., Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations. Cancer Discov. 4 (2014), 905–913.
121. Yoshii, S.R., Kuma, A., Akashi, T., Hara, T., Yamamoto, A., Kurikawa, Y., Itakura, E., Tsukamoto, S., Shitara, H., Eishi, Y., Mizushima, N., Systemic analysis of Atg5-null mice rescued from neonatal lethality by transgenic ATG5 expression in neurons. Dev. Cell 39 (2016), 116–130.
122. Yue, Z., Jin, S., Yang, C., Levine, A.J., Heintz, N., Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 15077–15082.
123. Zhang, Z., Miah, M., Culbreth, M., Aschner, M., Autophagy in neurodegenerative diseases and metal neurotoxicity. Neurochem. Res. 41 (2016), 409–422.
124. Zhong, Z., Sanchez-Lopez, E., Karin, M., Autophagy, inflammation, and immunity: a troika governing cancer and its treatment. Cell 166 (2016), 288–298.